Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 2 ( March-April, 2022 ) > List of Articles

Original Article

HELLP Syndrome among Pregnant Women Delivering at a Tertiary Care Hospital in Kathmandu: A Descriptive Cross-sectional Study

Pooja Paudyal, Prezma Shrestha, Sunita Bajracharya, Ashma Rana

Keywords : Hemolysis, Elevated liver enzymes, and low platelet syndrome, Maternal and perinatal outcome, Pregnancy

Citation Information : Paudyal P, Shrestha P, Bajracharya S, Rana A. HELLP Syndrome among Pregnant Women Delivering at a Tertiary Care Hospital in Kathmandu: A Descriptive Cross-sectional Study. J South Asian Feder Obs Gynae 2022; 14 (2):132-135.

DOI: 10.5005/jp-journals-10006-2043

License: CC BY-NC 4.0

Published Online: 21-06-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Background: Hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome is a serious obstetric complication with high risk of adverse maternal and perinatal outcomes. The aim of the study was to find the prevalence of HELLP syndrome and to analyze the maternal and perinatal outcomes. Methods: This was a descriptive cross-sectional study conducted in a tertiary care center from April 13, 2016, to April 12, 2020, after obtaining ethical clearance from the Institutional Review Committee. All the women with HELLP syndrome who delivered in the hospital during the study period were enrolled. A convenience sampling technique was used. Data were analyzed using the Statistical Package for the Social Sciences version 24 software. Descriptive analysis was done and frequency and proportion were calculated for binary data. Results: Prevalence of HELLP syndrome was 0.23%. The majority of the cases were in the 25–29 years age-group and the mean maternal age was 28.05 years. Twenty-seven (61.36%) were primigravida. Of 44, 27 (61.36%) delivered through lower segment cesarean section. Nineteen (43.18%) women were admitted to the high dependency unit. There were four (9.1%) maternal deaths. Most (68.18%) of the babies were preterm and 62.5% of the live-born babies were admitted to the neonatal intensive care unit. There were 20 perinatal deaths with a perinatal mortality of 45.45%. Conclusion: Hemolysis, elevated liver enzymes, and low platelet syndrome is a dreadful complication with high morbidity and mortality. Timely termination of pregnancy is warranted to arrest further progress of pathophysiology. Clinical significance: Outcomes in HELLP syndrome can be improved with early diagnosis and timely intervention.

PDF Share
  1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142(2):159–167. DOI: 10.1016/s0002-9378(16)32330-4.
  2. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169(4): 1000–1006. DOI: 10.1016/0002-9378(93)90043-i.
  3. Audibert F, Friedman SA, Frangieh AY, et al. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175(2): 460–464. DOI: 10.1016/s0002-9378(96)70162-x.
  4. Martin JN Jr, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180(6 Pt 1):1373–1384. DOI: 10.1016/s0002-9378(99)70022-0.
  5. Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102(2):111–117. DOI: 10.1111/j.1471-0528.1995.tb09062.x.
  6. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195(4):914–934. DOI: 10.1016/j.ajog.2005.08.044.
  7. Geary M. The HELLP syndrome. Br J Obstet Gynaecol 1997;104(8): 887–891. DOI: 10.1111/j.1471-0528.1997.tb14346.x.
  8. Sitaula S, Manandhar T, Thapa BD, et al. Prevalence of hemolysis, elevated liver enzymes, low platelet count syndrome in pregnant women in a tertiary care hospital. JNMA J Nepal Med Assoc 2020;58(226):405–408. DOI: 10.31729/jnma.4921.
  9. Murray D, O'Riordan M, Geary M, et al. The HELLP syndrome: maternal and perinatal outcome. Ir Med J 2001;94(1):16–18. PMID: 11322219.
  10. Lakshmi NK, Kavitha G, Prabha Devi K, et al. Study on HELLP syndrome–maternal and perinatal outcome. Int J Reprod Contracept Obstet Gynecol 2017;6:714–719. DOI: 10.18203/2320-1770.ijrcog20170411.
  11. Yıldırım G, Güngördük K, Aslan H, et al. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome. J Turk Ger Gynecol Assoc 2011;12(2):90–96. DOI: 10.5152/jtgga.2011.22.
  12. Kapan M, Evsen MS, Gumus M, et al. Subcapsular liver hematoma in HELLP syndrome: case report. Gastroenterology Res 2010;3(3): 144–146. DOI: 10.4021/gr2010.04.178e.
  13. Sujatha M, Meena M. A comparative study of maternal and perinatal outcome in patients with and without HELLP syndrome. Int J Reprod Contracept Obstet Gynecol 2017;6(1):49–53. DOI: 10.18203/2320-1770.ijrcog20164420.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.